Levi & Korsinsky is investigating potential claims of against the board
of directors of Walgreen Co. (“Walgreen” or the “Company”) (NYSE: WAG).
For more information, click here: http://zlk.9nl.com/walgreen-wag/.
On June 11, 2013, Walgreen entered into a settlement agreement with the
Drug Enforcement Administration in connection with civil charges that
the Company had practiced improper distribution of prescription
painkillers. Mark R. Trouville, Special Agent of the DEA’s Miami field
office, called Walgreen’s actions “a clear example of inexcusable
corporate conduct that existed only for greed and profit.” Under the
settlement, Walgreen agreed to an $80 million payout that is expected to
negatively impact Walgreen stock price by 4 to 6 cents per share in the
third quarter of 2013. The Company is also required to surrender its DEA
registrations at six of its more than 800 Florida pharmacies until May
2014 and at a Florida distribution center until September 2014.
If you own Walgreen stock and wish to obtain additional information
about the investigation and your legal rights, please contact Joseph E.
Levi, Esq. either via email at jlevi@zlk.com
or by telephone at (877) 363-5972, or visit http://zlk.9nl.com/walgreen-wag/.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, and Washington D.C. The firm has extensive expertise in
prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and
shareholder lawsuits. Attorney advertising. Prior results do not
guarantee similar outcomes.
Copyright Business Wire 2013